FDA Says Levemir OK for Pregnant Women


By: Diabetes Health Staff

The U.S. Food and Drug Administration says that Levemir is safe for use by pregnant women and does not increase the risk of harm to children in the womb.

Levemir (insulin detemir), manufactured by Novo Nordisk, is a long-acting insulin analog used to maintain insulin basal levels. Both type 1s and type 2s use it.

The FDA says it based its decision on a clinical trial that involved 310 women.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.